Novo Nordisk is a leading global pharmaceutical company founded in 1923 and headquartered in Denmark. Our mission is to drive the change in the fight against serious chronic diseases, building on our legacy in treating diabetes. We do this through scientific breakthroughs, expanding access to our medicines and efforts to prevent and ultimately cure disease. Novo Nordisk has approximately 78,400 employees in 80 countries and offers its products in approximately 170 countries. For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube
